[Home]
[Full version]
Ending apathy in an age of tuberculosis drug resistance
Mar 25 ,Medicine & Health
A primary focus on AIDS and lack of access to cheap life-saving medication has left the world potentially facing an epidemic of virtually untreatable tuberculosis (TB), an ANU academic has warned.
Senior Research Fellow at thSenior Research Fellow at the University’s Centre for Applied Philosophy and Public Ethics, Dr Michael Selgelid is warning on World TB Day (March 24) that more needs to be done to stop the spread of TB – a disease that still kills 1.7 million people each year.
Dr Selgelid said that it was a disgrace that more than 50 years after a cure for TB was found, the disease should still cause such a large death toll around the world.
“The global TB status quo is shameful,” said Dr Selgelid. “Though cures have existed since the 1950s, TB is still the second leading infectious cause of mortality – a close runner up to AIDS. One third of the world population is infected with latent TB and 10 per cent of these are expected to develop active illness at some time in their lives.”
The threat of TB has increased significantly in the last 20 years, first through the detection of Multi-Drug Resistance (MDR) TB and recently through ‘Extreme’ or ‘Extensively’ Drug-Resistant (XDR) TB. XDR-TB, said Dr Selgelid, has been found in 45 countries and every region of the world.
“Because XDR-TB is virtually untreatable we have returned to a situation analogous to the pre-antibiotic era. This has occurred for a number of reasons, including that not enough people in developing countries could afford to complete their treatment.
“It’s astonishing that TB has largely escaped the attention of bioethicists. A medical literature database search found 2998 publications addressing AIDS, but only 179 addressing TB and ethics. But while AIDS has been highly politicised, TB has primarily affected the poor so there hasn’t been as much advocacy of TB control in the rich countries where most bioethicists work.”
He added that with World TB Day approaching and the threat of XDR-TB, renewed efforts needed to be made to address the problem.
“XDR-TB should be a wake-up call and galvanise policy makers worldwide. Developed countries must do more to improve health care in developing countries. In addition to the moral imperative to easing the untold suffering and millions of unnecessary deaths, there are straightforward self-interested reasons – bad health in poor countries jeopardises the health of populations in Australia and other rich countries.
“World TB Day should remind us that it’s high time to stop TB – it could and should have been stopped long ago.”
e University’s Centre for Applied Philosophy and Public Ethics, Dr Michael Selgelid is warning on World TB Day (March 24) that more needs to be done to stop the spread of TB – a disease that still kills 1.7 million people each year.
Dr Selgelid said that it was a disgrace that more than 50 years after a cure for TB was found, the disease should still cause such a large death toll around the world.
“The global TB status quo is shameful,” said Dr Selgelid. “Though cures have existed since the 1950s, TB is still the second leading infectious cause of mortality – a close runner up to AIDS. One third of the world population is infected with latent TB and 10 per cent of these are expected to develop active illness at some time in their lives.”
The threat of TB has increased significantly in the last 20 years, first through the detection of Multi-Drug Resistance (MDR) TB and recently through ‘Extreme’ or ‘Extensively’ Drug-Resistant (XDR) TB. XDR-TB, said Dr Selgelid, has been found in 45 countries and every region of the world.
“Because XDR-TB is virtually untreatable we have returned to a situation analogous to the pre-antibiotic era. This has occurred for a number of reasons, including that not enough people in developing countries could afford to complete their treatment.
“It’s astonishing that TB has largely escaped the attention of bioethicists. A medical literature database search found 2998 publications addressing AIDS, but only 179 addressing TB and ethics. But while AIDS has been highly politicised, TB has primarily affected the poor so there hasn’t been as much advocacy of TB control in the rich countries where most bioethicists work.”
He added that with World TB Day approaching and the threat of XDR-TB, renewed efforts needed to be made to address the problem.
“XDR-TB should be a wake-up call and galvanise policy makers worldwide. Developed countries must do more to improve health care in developing countries. In addition to the moral imperative to easing the untold suffering and millions of unnecessary deaths, there are straightforward self-interested reasons – bad health in poor countries jeopardises the health of populations in Australia and other rich countries.
“World TB Day should remind us that it’s high time to stop TB – it could and should have been stopped long ago.”
Source: ANU
Related stories:
Depression common among Rwandan youth who head households
More than half of orphaned youth age 12 to 24 who head households in rural Rwanda meet criteria for depression, according to a report in the August issue of
Archives of Pediatrics & Adolescent Medicine.
Americans adopting HIV-positive kids from Ethiopia
(AP) -- Solomon Henderson inherited just three things from his birth parents, who left him at an Ethiopian orphanage when he was 1 year old: a picture of Jesus, a plastic crucifix and HIV.
Operations research promises continued gains for HIV treatment in resource-limited countries
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it. A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.
'Nutraceuticals' could prevent diabetes
People at high risk for developing type 2 diabetes might be able to delay or prevent the disease by taking certain food supplements and making lifestyle changes, according to a new book by Dr. James W. Anderson, an internationally recognized authority on metabolic diseases and weight loss and professor emeritus of medicine and clinical nutrition at the University of Kentucky College of Medicine.
New male circumcision device for HIV prevention studied by NewYork-Presbyterian/Weill Cornell
With the recent endorsement by the World Health Organization (WHO) and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and cost-effective circumcision services. This is especially the case in Africa where HIV/AIDS continues to spread at an epidemic rate.
Common vaginal infection may increase risk of HIV infection
A common vaginal infection may make women more susceptible to contracting HIV, the virus that causes AIDS, University of North Carolina at Chapel Hill School of Public Health researchers have found.
Sensitive testing reveals drug-resistant HIV with possible consequences for treatment
Drug-resistant HIV at levels too low to be detected by standard tests is not unusual and may contribute to treatment failure, according to research published in
PLoS Medicine.
AIDS-hit Swaziland population drops
The population of the AIDS-riven kingdom of Swaziland, already one of the smallest countries in Africa, has fallen by around a fifth in the last decade, figures showed Friday.
[Home]
[Full version]